RxDoctor Payments Data

Zak Loring

Clinical Cardiac Electrophysiology · Durham, NCNPI 1467795609

Payments from drug & device makers

What this record shows

This record is dominated by grants: $26,250 of the $41,470 with a category attached, or 63.3%. Boston Scientific accounts for 65.0% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2020 at $11,377 and has fallen 90.0% since, to $1,138 in 2025.

$41,470in general payments, 2019–2025

Across 160 payments — averaging $259.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$27K
  • Medtronic$14K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$389
  • Biosense Webster, Inc.$257
  • Biotronik Inc.$149
  • Amgen$50
  • plus $41 from 2 others
$49,738in research payments, 2019–2025

Across 5 payments — averaging $9947.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$50K

What the payments were for

  • Consulting fees$7,16317%
  • Grants$26,25063%
  • Travel & lodging$3,3158%
  • Food & beverage$4,58511%
  • Education$1580%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$41,470 in reported general payments places this provider in the 65th percentile of 98 clinical cardiac electrophysiology providers in North Carolina.

See all clinical cardiac electrophysiology providers in North Carolina

Medicare billing

Part B allowed, 2024
$53,431
Medicare patients
383
Services billed
791

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban55$51,043
Metoprolol Succinate32$278
Amiodarone Hcl14$207

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →